Efficacy of entecavir for chronic hepatitis B patients after curative treatment of hepatocellular carcinoma :randomized controlled trial
Not Applicable
- Conditions
- Chronic hepatitis B
- Registration Number
- JPRN-UMIN000001000
- Lead Sponsor
- niversity of Tokyo Department of Gastroenterology, Faculty of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 44
Inclusion Criteria
Not provided
Exclusion Criteria
The exclusion criteria are as follows: a previous history of a severe drug hypersensitivity against an ingredients of Entecavir, extrahepatic metastasis lesion of HCC, malignancy except for HCC (double cancer), severe renal disease (BUN more than 40 mg/dl or creatinine more than 2.0 mg/dl), the presence of other forms of liver disease such as auto immune hepatitis, coinfection with hepatitis C, history of liver transplantation, participation in another clinical trial, and doctors' stop not to register to the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method